Mild Cognitive Impairment International Perspectives Psychology Press & Routledge Classic Editions Series
Coordonnateurs : Tuokko Holly A., Hultsch David F.
The Classic Edition of this foundational text includes a new preface from Holly A. Tuokko, examining how the field of Mild Cognitive Impairment (MCI) has developed since first publication. Bringing together research from multiple studies and perspectives from various countries, the volume identifies MCI as an important clinical transition between normal aging and the early stages of Alzheimer's disease (AD).
The up-to-date preface highlights the expansion in research, examining the benefits of various pharmacological, cognitive and behavioral approaches to intervention. Influenced by recent findings in neuroplasticity across the lifespan, the book recognizes the importance of intervention at the earliest stages of the decline trajectory. It revisits the contested diagnostic approaches for MCI as well as the varying prevalence of MCI internationally, yet points to the need for further longitudinal studies to fully understand the condition.
Mild Cognitive Impairment continues to provide a comprehensive resource for clinicians, researchers and students involved in the study, diagnosis, treatment and rehabilitation of people with MCI.
About the editors
List of contributors
From the series editor
Introduction to the Classic Edition
Part I
Introduction
- An overview of mild cognitive impairment
HOLLY A. TUOKKO AND IAN MCDOWELL
Part II
General Population Research on MCI
2 The PAQUID study
COLETTE FABRIGOULE, PASCALE BARBERGER-GATEAU, AND JEAN-FRANÇOIS DARTIGUES
3 Cognitive impairment in elderly persons without dementia: Findings from the Kungsholmen Project
KATIE PALMER, LARS BACKMAN, BRENT J. SMALL, AND LAURA FRATIGLIONI
4 Population levels of mild cognitive impairment in England and Wales
JANE FLEMING, FIONA E. MATTHEWS, MARK CHATFIELD, AND CAROL BRAYNE
5 The Melbourne Aging Study
ALEXANDER COLLIE, PAUL MARUFF, DAVID G. DARBY, COLIN MASTERS, AND JON CURRIE
Part III
Specific Samples
6 Mild cognitive impairment in the Religious Orders Study
ROBERT S. WILSON, NEELUM T. AGGARWAL, AND DAVID A. BENNETT
7 A perspective from the Mayo Clinic
GLENN SMITH, MARY MACHULDA, AND KEJAL KANTARCI
8 Prediction of probable Alzheimer's disease: The Sunnybrook Memory Study
MARY C. TIERNEY
9 Studies in the Leipzig Memory Clinic: Contribution to the concept of mild cognitive impairment
HENRIKE WOLF AND HERMANN-JOSEF GERTZ
Part IV
Interventions
10 Emerging pharmacological therapies for mild cognitive impairment
HOWARD CHERTKOW
11 Cognition-based therapies and mild cognitive impairment
ROBERT T. WOODS AND LINDA CLARE
12 Combined therapies in mild cognitive impairment
KEVIN PETERS AND GORDON WINOCUR
Part V
Summary and Future Directions
13 The future of mild cognitive impairment
HOLLY A. TUOKKO AND DAVID F. HULTSCH
Author index
Subject index
Holly A. Tuokko was a Professor in the Department of Psychology and Institute on Aging and Lifelong Health at the University of Victoria. She was awarded Senior Investigator status through the Canadian Institutes of Health Research, Institute of Aging (2002–2007), for her program of research on mental health and aging.
David F. Hultsch was a Professor of Psychology at the University of Victoria from 1984 onward, with a major research focus on cognition and aging. He was a founder of the journal Aging, Neuropsychology, and Cognition, serving as co-editor for 10 years.
Date de parution : 01-2020
15.2x22.9 cm
Date de parution : 01-2020
15.2x22.9 cm
Thème de Mild Cognitive Impairment :
Mots-clés :
pharmacological approaches; neuroplasticity; Mild Cognitive Impairment; Alzheimer's disease; behavioral approaches; CDR Score; aMCI Patients; MCI Prevalence; Multidomain MCI; American Psychiatric Association; Amnestic MCI; MCI Cohort; MCI Sample; MCI Criterion; Accelerated Failure Time Models; MCI Group; Biological Outcome Measures; MMSE Score; Subjective Memory Complaints; Executive Control Deficits; MCI Patient; Stable MCI; MCI Subtype; IADL Item; MCI Subgroup; Nonprogressive Acquired Brain Injury; PAQUID Study; Medical Research Council Cognitive Function; Global Cognitive Functioning